Literature DB >> 27795506

TAFRO syndrome with primary Sjogren's syndrome.

Nozomi Iwanaga1, Kohei Harada, Yoshika Tsuji, Chieko Kawahara, Kazuhiro Kurohama, Yasumori Izumi, Shinichiro Yoshida, Keita Fujikawa, Masahiro Ito, Atsushi Kawakami, Kiyoshi Migita.   

Abstract

A 25-year-old woman diagnosed 1 year earlier with Primary Sjogren's syndrome was admitted to a nearby hospital with fever of unknown origin. Examination revealed anasarca, systemic lymphadenopathy, hepatosplenomegaly and high C-reactive protein level. The patient's symptoms were initially suspected to be caused by severe bacterial infection with Sjogren's syndrome flare. She was given antibiotics and prednisolone (PSL) at 50 mg/day. However, the patient developed anemia and thrombocytopenia and was transferred to our hospital for further care. Histological examination of the right inguinal lymph node showed neutrophilic infiltration. Bone marrow aspiration revealed a normocellular marrow with increased megakaryocytes and mild reticulin fiber hyperplasia. After initiation of minocycline hydrochloride, the patient's symptoms improved. However, as PSL was tapered, her symptoms worsened. The patient's clinical symptoms and laboratory data improved again with initiation of intravenous steroid pulse therapy and cyclosporine. TAFRO syndrome is characterized by a constellation of symptoms: Thrombocytopenia, Anasarca, Fever, Reticulin fibrosis and Organomegaly. Although histological findings of the lymph node in this case differed from previous reports, the patient's other symptoms and clinical course were similar to TAFRO syndrome. TAFRO syndrome can occur with several diseases, including infection, rheumatic disease and malignancies. We report a case in which infection might have triggered TAFRO syndrome.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27795506     DOI: 10.2177/jsci.39.478

Source DB:  PubMed          Journal:  Nihon Rinsho Meneki Gakkai Kaishi        ISSN: 0911-4300


  7 in total

1.  Idiopathic multicentric Castleman disease with positive antiphospholipid antibody: atypical and undiagnosed autoimmune disease?

Authors:  Yoshito Nishimura; Asami Nishikori; Haruki Sawada; Torrey Czech; Yuki Otsuka; Midori Filiz Nishimura; Hiroki Mizuno; Naoki Sawa; Shuji Momose; Kumiko Ohsawa; Fumio Otsuka; Yasuharu Sato
Journal:  J Clin Exp Hematop       Date:  2022-03-05

2.  TAFRO syndrome with renal biopsy successfully treated with steroids and cyclosporine: a case report.

Authors:  Takahide Iwasaki; Kosuke Mizusaki; Miwa Masumoto; Yuko Minagawa; Kouta Azuma; Tetsuya Furukawa; Makoto Yoshida; Takahiro Kuragano
Journal:  BMC Nephrol       Date:  2022-07-23       Impact factor: 2.585

3.  International definition of iMCD-TAFRO: future perspectives.

Authors:  Yoshito Nishimura; Midori Filiz Nishimura; Yasuharu Sato
Journal:  J Clin Exp Hematop       Date:  2022-04-27

4.  TAFRO Syndrome in Caucasians: A Case Report and Review of the Literature.

Authors:  Céline Louis; Sandrine Vijgen; Kaveh Samii; Yves Chalandon; Louis Terriou; David Launay; David C Fajgenbaum; Jörg D Seebach; Yannick D Muller
Journal:  Front Med (Lausanne)       Date:  2017-09-22

5.  Sjögren's syndrome manifesting as clinicopathological features of TAFRO syndrome: A case report.

Authors:  Shino Fujimoto; Hiroshi Kawabata; Nozomu Kurose; Haruka Kawanami-Iwao; Tomoyuki Sakai; Takafumi Kawanami; Yoshimasa Fujita; Toshihiro Fukushima; Yasufumi Masaki
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

6.  Severe refractory TAFRO syndrome requiring continuous renal replacement therapy complicated with Trichosporon asahii infection in the lungs and myocardial infarction: an autopsy case report and literature review.

Authors:  Arata Hibi; Ken Mizuguchi; Akiko Yoneyama; Takahisa Kasugai; Keisuke Kamiya; Keisuke Kamiya; Chiharu Ito; Satoru Kominato; Toshiyuki Miura; Katsushi Koyama
Journal:  Ren Replace Ther       Date:  2018-04-04

7.  Development of severe thrombocytopenia with TAFRO syndrome-like features in a patient with rheumatoid arthritis treated with a Janus kinase inhibitor: A case report.

Authors:  Keiichiro Kadoba; Daisuke Waki; Keisuke Nishimura; Hiroki Mukoyama; Rintaro Saito; Hiroyuki Murabe; Toshihiko Yokota
Journal:  Medicine (Baltimore)       Date:  2020-10-16       Impact factor: 1.817

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.